Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial


Biteker M., Duran N. E. , Kaya H., Gunduz S., Tanboga H. I. , Gokdeniz T., et al.

CLINICAL RESEARCH IN CARDIOLOGY, cilt.100, ss.571-577, 2011 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 100 Konu: 7
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1007/s00392-010-0279-7
  • Dergi Adı: CLINICAL RESEARCH IN CARDIOLOGY
  • Sayfa Sayısı: ss.571-577

Özet

Levosimendan is a promising new inodilator agent but its effectiveness in peripartum cardiomyopathy (PPCM) has not been tested in a clinical trial. The authors sought to evaluate the effect of levosimendan therapy and to determine the predictors of clinical outcome in patients with PPCM.